United Therapeutics Corporation Deferred Tax Assets, Operating Loss Carryforwards
United Therapeutics Corporation (UTHR) had Deferred Tax Assets, Operating Loss Carryforwards of $22.20 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-25
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $22.20M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $19.80M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $21.40M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $9.50M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $22.20M 10-K · filed 2026-02-25 | |
| 2024-12-31 | $19.80M 10-K · filed 2026-02-25 | |
| 2023-12-31 | $21.40M 10-K · filed 2025-02-26 | |
| 2022-12-31 | $9.50M 10-K · filed 2024-02-21 | |
| 2021-12-31 | $8.30M 10-K · filed 2023-02-22 | |
| 2020-12-31 | $9.70M 10-K · filed 2022-02-24 | |
| 2019-12-31 | $8.80M 10-K · filed 2021-02-24 | $6.70M 10-K · filed 2020-02-26 |
| 2018-12-31 | $34.30M 10-K · filed 2020-02-26 | |
| 2017-12-31 | $2.40M 10-K · filed 2019-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |